Intriguingly, human ATM and SMG1 phosphorylate identical residues in tumour suppressor p53 and SMG-2/UPF1, and combined loss of ATM and SMG-1 increases haematopoietic cancer incidence (9). This evidence concerns the gene SMG1 and hematopoietic and lymphoid cell neoplasm.